Blueprint Medicines Corp (NASDAQ:BPMC) traded at $128.4 at close of the session on Monday, June 23 and made an upward move of 0.16%% on its previous day’s price. Looking at the stock we see that its previous close was $128.2 and the beta (5Y monthly)
Blueprint Medicines Corp (NASDAQ:BPMC) shares, rose in value on Wednesday, June 18, with the stock price down by -0.09% to the previous day’s close as strong demand from buyers drove the stock to $128.12. Actively observing the price movement in the last trading, the stock
The trading price of Blueprint Medicines Corp (NASDAQ:BPMC) closed lower on Friday, June 13, and closing at $127.96, -0.19% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $127.945 and $128.27. In examining the
Blueprint Medicines Corp (NASDAQ:BPMC) price remained unchanged from its previous close. A look at the daily price movement shows that the last close reads $127.97. Taking into account the 52-week price action we note that the stock hit a 52-week high of $128.24 and 52-week
Blueprint Medicines Corp (NASDAQ:BPMC) concluded the trading at $127.90 on current market day with a fall of -0.16% from its closing price on previous day. Considering stock’s 52-week price range provides that BPMC hit a high price of $128.15 and saw its price falling to
Blueprint Medicines Corp (NASDAQ:BPMC) traded at $127.79 at close of the session on Monday, June 02 and made an upward move of 26.09% on its previous day’s price. Blueprint Medicines Corp has a market cap of $8.25 billion and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.